Time delay avoids interaction between guar gum and sulphadiazine after oral administration

Journal of Drug Delivery Science and Technology

Volumn 14, Issue 5, 2004, Pages 395-399

  Montejo, C ^a   Barcia, E ^b   Fernndez Carballido A ^b   Molina Martinez I T ^b  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Bioequivalence; Guar gum; Residence efficiency; Sulphadiazine

Indexed keywords

DRUG METABOLITE; GUAR GUM; SULFADIAZINE;

ADULT; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG SOLUBILITY; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SINGLE DRUG DOSE; URINARY EXCRETION;

EID: 5644294511     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-2247(04)50069-2     Document Type: Article

References (37)

1. GATENBY S.J., ELLIS P.R., MORGAN L.M., JUDD P.A. - Effect of partially depolymerised guar gum on acute metabolic variables in patients with non-insulin-dependent diabetes. - Diabetic Medicine, 13 (4), 358-364, 1996.
2. NUTTALL F.Q. - Dietary fiber in the management of diabetes. - Diabetes, 42 (4), 503-508, 1993.
3. GRAY D.S. - The clinical uses of dietary fiber. - Am Fam Physician, 51, 419-423, 1995.
4. ANDERSON J.W. - High-fiber diets for obese diabetic men on insulin therapy: short-term and long-term effects. - Curr Top Nutr Dis, 14, 49-53, 1985.
5. CHANDALIA M., GARG A., LUTJOHANN D., VON BERGMANN K., GRUNDY S., BRINKLEY L. - Beneficial effects of high dietary fiber in patients with type 2 diabetes mellitus. - N Engl J Med, 342, 1392-1398, 2000.
6. WURSCH P., PI-SUNYER F.X. - The role of viscous soluble fiber in the metabolic control of diabetes: a review with special emphasis on cereals rich in beta-glucan. - Diabetes Care, 20, 1774-1780, 1997.
7. CHUANG L.M., JOU T.S., YANG W.S., WU H.P., TAI T.Y., LIN B.J. - Therapeutic effect of guar gum in patients with non-insulin-dependent diabetes mellitus. - J Formos Med Assoc, 91, 15-19, 1992.
8. FAIRCHILD R.M., ELLIS P.R., BYRNE A.J., LUZIO S.D., MIR M.A. - A new breakfast cereal containing guar gum reduces postprandial plasma glucose and insulin concentrations in normal-weight human subjects. - Br J Nutr, 76, 63-73, 1996.
9. SIERRA M., GARCÍA J.J., FERNÁNDEZ N., DIEZ M.J., CALLE A.P., Farmafibra Group. - Therapeutic effects of psyllium in type 2 diabetic patients. - Eur J Clin Nutr, 56 (9), 830-842, 2002.
10. GIN H., ORGERIE M.B., AUBERTIN T. - The influence of guar gum on absorption of metformin from the gut in healthy volunteers. - Horm Metabol Res, 21, 81-83, 1989.
11. HOPPU K., TUOMISTO J., KOSKIMIES O., SIMELL O. - Food and guar decrease absorption of trimethoprim. E- ur J Clin Pharmacol, 32, 427-429, 1987.
12. BRENELLI S.L., CAMPOS S.D., SAAD M.J. - Viscosity of gums in vitro and their ability to reduce postprandial hyperglycemia in normal subjects. - Braz J Med Biol Res, 30, 1437-1440, 1997.
13. OU S., KWOK K., LI Y., FU Y. - In vitro study of possible role of dietary fiber in lowering postprandial serum glucose. - J Agr Food Chem, 49 (2), 1026-1029, 2001.
14. SIERRA M., GARCÍA J.J., FERNÁNDEZ N., DÍEZ M.J., CALLE A.P., SAHAGÚN A.M. - Effects of ispaghula husk and guar gum on postprandial glucose and insulin concentrations in healthy subjects. - Eur J Clin Nutr, 55 (4), 235-243, 2001.
15. SHIMA K., TKAGOMI H., TANAKA A., EZAKI A., KUMAHARA T. - Effect of dietary fiber, Konjac Mannan and guar on absorption of sulfonylurea in man. - Nutr Rep In, 26, 297-302, 1982.
16. KARTTUNEN P., SODERVIK H., SILVASTI M., UUSITUPA M. - The effects of guar gum on glibenclamide absorption and metabolic control of type II diabetics. - Acta Endocrinol, 115, 282-285, 1987.
17. SCHEEN A.J. - Clinical pharmacokinetics of metformin. - J Clin Pharmacokin, 30 (5), 359-371, 1996.
18. CADÓRNIGA R., HERRERO R., GONZÁLEZ E., MOLINA I.T., OLMEDA J.M., GUTIÉRREZ J.A. - Guar gum ingestion modifies cephalexin absorption. - Third European Congress of Biopharmaceutics and Pharmacokinetics, Friburg, 21-24 April 1987, Vol. I, pp. 121-129.
19. HUUPPONEN R., SEPPALA P., IISALO E. - Effect of guar gum, a fiber preparation, on digoxin and penicillin absorption in man. - Eur J Clin Pharmacol, 26, 279-281, 1984.
20. LEMBCKE B., HASLER K., KRAMER P., CASPARY W.F., CREUTZFELDT W. - Plasma digoxin concentrations during administration of dietary fiber (guar gum) in man. - Z Gastroenterología, 20, 164-167, 1982.
21. FUGH-BERMAN A. - Herb-drug interactions. - Lancet, 355 (9198), 134-138, 2000.
22. REPPAS C., ELEFTHERIOU P., MACHERAS P., SYMILLIDES, JB., DRESSMAN JB. - Effect of elevated viscosity in the upper gastrointestinal tract on drug absorption in dogs. - Eur J Pharm Sci, 6, 131-139, 1998.
23. UUSITUPA M., SÖDERVIK H., SILVASTI M., KARTTUNEN P. - Effects of gel forming dietary fiber, guar gum, on the absorption of glibenclamide and metabolic control and serum lipids in patients with non-insulin-dependent (type 2) diabetes. - Int J Clin Pharmacol Ther Toxicol, 28, 153-157, 1990.
24. ALKAYSI H.N., SALEM M.A., GHARABEIH A.M., GHARABEIH K.I., BADWAN A.A. - Bioequivalence studies on tablet formulation of tetroxoprim and sulphadiazine. - J Clin Pharm Ther, 17 (2), 97-99, 1992.
25. JACK DB. - Handbook of Clinical Pharmacokinetic Data. - Macmillan Publishers Ltd, Basinngstoke, 1992, p. 22.
26. Clinical Pharmacokinetics. - Drug Data Handbook, 3rd Ed., Adis International Ltd, Auckland, 1998, p. 26.
27. NEUGEBAUER G., BETZIEN G., HRSTKA V., KAUFMANN B, VON MOLLENDORF E., ABSHAGEN U. - Absolute bioavailability and bioequivalence of glibenclamide (semi-euglucon N). - Int J Clin Pharmacol Ther Toxicol, 23 (9), 453-460, 1985.
28. AMIDON GL., LENNERNAS H., SHAH VP., CRISON JR. - A theoretical basis for a biopharmaceutic drug classification: the correlation of in vivo drug product dissolution and in vivo bioavailability. - Pharm Res, 12 (3), 413-420, 1995.
29. KAMBERI M., KOTEGAWA T., TSUTSUMI K., NAKAMURA K., NAKANO S. - Sparfloxacin pharmacokinetics in healthy volunteers: The influence of acidification and alkalinization. - Eur J Clin Pharmacol, 54 (8), 633-637, 1998.
30. KAMBERI M., TSUTSUMI K., KOTEGAWA T., KAWANO K., NAKAMURA K., NIKKI Y., NAKANO S. - The influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin. - Antimicrob Agents Chemother, 43 (3), 525-529, 1999.
31. GURON G., MARCUSSEN N., FRIBERG P. - Urinary acidification and net acid excretion in adult rats treated neonatally with enalapril. - Am J Physiol Regul lntegr Comp Physiol, 274 (643-6), R1718-R1724, 1998.
32. MONTEJO C., MOLINA-MARTÍNEZ I.T., BARCIA E., CADÓRNIGA R. - The influence of guar gum on the oral absorption of sulphadiazine. - Fifth European Congress of Biopharmaceutics and Pharmacokinetics, Brussels, 20-22 April 1993, Vol. 70, pp. 20-22.
33. International Conference on Harmonisation (ICH). - Validation of analytical procedures: methodology, ICH Q2B, 1996.
34. Committee for Proprietary Medicinal Products (CPMP). - Note for Guidance on the Investigation of Bioavailability and Bioequivalence. - The European Agency for the Evaluation of Medicinal Products. (CPMP/EWP/QWP/1401/98).
35. SIEGEL S. - In: Estadistica no Paramétrica, 3rd ed., Ed. Trillas, México, 1990, pp. 99-112.
36. CALABI V., VANNINI E., FARINA N. - Farmacocinética della sulfametopirazina. - II Fármaco, 28 (11), 585-595, 1983.
37. KHAN K.A., RHODES C.T. - The concept of dissolution efficiency. - J Pharm Pharmacol, 27, 48-49, 1975.